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INTRODUCTION
 Gonorrhea caused by Neisseria gonorrhoeae (N. 
gonorrhoeae) is the second most common sexually 
transmitted infection (STI) worldwide. The precise 
global burden of N. gonorrhoeae is difficult to estab-
lish because of the lack of diagnostic facility and/or 
reporting systems in many parts of the world. The 
World Health Organization (WHO) estimates that 
in each year 78 million new cases of gonorrhea oc-
cur among adolescents and adults aged 15-49 years 
worldwide with a global incidence rate of 19 per 
1000 females and 24 per 1000 males. In South-East 
Asia, each year 11.4 million new cases of gonorrhea 
were estimated.1 In Bangladesh, the prevalence rate 
of gonorrhea is not well documented but it was 
found to be 27.81% among STIs and second only to 
non-gonococcal urethritis (NGU) noted in a retro-
spective large-scale study incorporating data from 
2003 to 2011 at a tertiary care hospital.2 Gonorrhea 
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ABSTRACT
Objectives: Successful treatment of gonorrhea has always been jeopardized by the emergence of 
resistance to antibiotics recommended as first-line therapies. The present investigation was carried out to 
demonstrate the current status of antimicrobial susceptibility of N. gonorrhoeae with a special reference 
to azithromycin and ceftriaxone.
Methods: Microscopical detection in Gram-stained smear and isolation by culture in Thayer-Martin medium 
were done for 60 clinically suspected gonorrhea patients using urethral discharge or prostatic secretion for 
male and endocervical secretion for female. Isolates of N. gonorrhoeae were subjected to antimicrobial 
susceptibility testing by modified Kirby Bauer disk diffusion method against eight antimicrobial drugs 
including azithromycin and ceftriaxone.
Results: Culture yielded a total of 25(42%) isolates of N. gonorrhoeae from 60 clinically suspected patients 
of both sexes; 21 from male (17 from urethral discharge and 04 from prostatic secretion) and 04 from 
female (endocervical secretion). Isolates of N. gonorrhoeae showed moderate to high resistance (60 to 
88%) to penicillin, tetracycline, cotrimoxazole, erythromycin, ciprofloxacin and cefixime. While resistance 
to azithromycin and ceftriaxone was 60% and 48% respectively, which was also moderate.
Conclusion: Our findings indicate moderate to the high resistance of N. gonorrhoeae to conventional 
antibiotics. It also showed moderate resistance to azithromycin and ceftriaxone, current dual therapy 
recommended by the WHO for the treatment of genital gonorrhea, which is alarming.
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was found to be much higher (35.8%) among female 
sex workers in Bangladesh.3
 Uncomplicated gonococcal infection commonly 
manifests as genital tract infections in both male 
and female but if untreated can lead to serious 
complication like infertility in both gender.4 The risk 
of complication increases with repeated gonococcal 
infection and it also increases the risk for HIV 
acquisition and transmission.5 Gram-stained smears 
can provide a presumptive diagnosis of gonorrhea, 
however, culture of urethral discharge and/or 
prostatic secretion in case of male and endocervical 
swab in case of female is the gold standard for the 
detection of N. gonorrhoeae with high sensitivity and 
specificity.6
 N. gonorrhoeae is a very well-known pathogen 
for its ever-increasing antimicrobial resistance, and 
more resistance is being observed especially in areas 
where ineffective treatment regimens are practiced. 
Control of gonorrhea largely relies on detection 
of cases followed by therapy however, successful 
treatment has always been hampered by emergence 
of resistance to each of the antibiotics recommended 
as first-line therapies. The WHO Global Gonococcal 
Antimicrobial Surveillance Programme (WHO 
GASP), monitors trends in drug-resistant gonorrhea 
and its data from 2009 to 2014 find widespread 
resistance to ciprofloxacin, increasing resistance 
to azithromycin (81%), and the emergence of 
resistance to the current last-resort treatment; the 
extended-spectrum cephalosporins (66%), oral 
cefixime or injectable Ceftriaxone.7 To minimize the 
development and spread of resistance, dual therapy 
consisting of ceftriaxone and azithromycin has been 
recommended recently as the first-line therapy 
in international guidelines. However, the first 
treatment failure with dual therapy was reported 
in 2016 in the United Kingdom and soon thereafter, 
a few more countries from Europe, America and 
Australia also reported various degree of resistance 
to dual therapy.8,9 To explore the current status 
of antimicrobial resistance of N. gonorrhoeae with 
special reference to azithromycin and ceftriaxone 
in Bangladesh, we conducted this cross-sectional 
investigation at a tertiary care teaching hospital.
METHODS
Patients: This was a descriptive cross-sectional 
investigation of clinically suspected patients of 
gonorrhea. The protocol of this investigation was 
approved by the ‘Ethical Review Committee’ of 
Rajshahi Medical College, Bangladesh for ethical 
issues related to this research. Purposive sampling 
technique was applied to include 60 clinically 
suspected cases of gonorrhea in male (15-55 yrs.) 
and female (15-45 yrs.) attending at the outpatient 
departments of Dermatology & Venereology and 
Gynecology of Rajshahi Medical College Hospital 
from January to December 2016. Relevant clinical 
and socio-demographic data were collected through 
clinical examination and personal interview and 
recorded systematically. Laboratory tests were 
done at the Department of Microbiology, Rajshahi 
Medical College, Bangladesh.
Samples and Culture: After obtaining informed 
written consent and taking all aseptic precautions, 
urethral swabs (60), prostatic secretion swabs (40) 
and endocervical swabs (20) were collected in du-
plicate from 60 clinically suspected cases at the de-
partment of Microbiology following standard tech-
niques of collection. First collected swab in each case 
was inoculated onto the Thayer-Martin medium 
(Oxoid, UK) aseptically following multiple strokes 
technique soon after collection and was incubated at 
37°C in 5-10% CO2 for 24 to 48 hours. CO2 was pro-
vided by a candle jar. Isolates of N. gonorrhoeae were 
identified based on colonial morphology (growth of 
typical colonies), Gram stain (Gram-negative intra-
cellular diplococci in stained smears), and oxidase 
reaction (oxidase-positive). Sugar fermentation test 
was further performed to confirm N. gonorrhoeae as 
glucose fermenter. The second swab samples were 
utilized for smear preparation in Gram staining to 
see Gram-negative intra or extracellular diplococci 
under bright field microscope.10
Antimicrobial Susceptibility Testing: Antimicrobial 
susceptibility testing (AST) was performed onto 
Chocolate agar medium by modified Kirby 
Bauer disk diffusion method with inoculums of 
0.5 McFarland standards.10 Antimicrobial disks 
(Oxoid, UK) of penicillin(10µg), tetracycline 
(30µg), erythromycin(15µg), cotrimoxazole(25µg)
,ciprofloxacin(5µg), cefixime (5µg), azithromycin 
(15µg) and ceftriaxone(30µg) were selected as 
per Clinical and Laboratory Standard Institute 
(CLSI) 2016 guideline.11Inoculated plates with the 
antimicrobial disks were incubated at 370C for 18-
24 hours in a humid atmosphere with 5-10% CO2 
provided by a candle jar. The diameters of the 
zones of inhibition around disks were measured in 
millimeter. Inhibition zone produced by each disk 
was considered into two susceptibility categories 
namely Sensitive (S) and Resistant (R) according to 
CLSI guideline.11 Staphylococcus aureus ATCC-25923 
was used for quality control in the interpretation of 
zone of inhibition by antimicrobial disk.
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Statistical Analysis: All data were entered into 
Statistical Package for Social Sciences (SPSS) 
version 21.0. Mean ± standard deviation (SD) was 
calculated for age in both genders. Frequencies with 
percentage were generated for categorical variables 
such as, number positive in laboratory tests, 
sociodemographic profiles of patients, number of 
antimicrobial-resistant cases etc.
RESULTS
 Laboratory findings and their correlation with 
sociodemographic profile of gonorrhea patients are 
shown in Table-I. The rate of microscopic detection 
and isolation in culture of N. gonorrhoeae was 
36(60%) and 25(42%) respectively. Both microscopy 
and culture yielded higher rate of detection from 
urethral discharge followed by endocervical and 
prostatic secretions. There was male preponderance 
(21 vs. 04) among culture-positive gonorrhea with 
highest detection rate found among 15-24 years 
age group in both sexes. Mean ± SD age in years 
for male and female was 27.52±70.55 and 23.50±4.90 
respectively. Occupation wise highest number 
09(43%) of gonorrhea cases was from student in case 
of male and housewife 03(75%) in case of female 
among seven different categories of occupations. 
Overwhelming majority (60%) of cases were from 
lower class (monthly income in BDT. 10000-15000) 
followed by middle class (40%) (monthly income in 
BDT. 15001-20000) for their socioeconomic status.
 Antimicrobial susceptibility testing results of 
N. gonorrhoeae isolates are shown in Table-II. It 
is evident from the results that N. gonorrhoeae 
showed moderate to high resistance (60 to 
88%) to conventional antibiotics; penicillin 
(88%), tetracycline (80%), cotrimoxazole (80%), 
erythromycin (72%), ciprofloxacin (68%) and 
cefixime (60%). While resistance to azithromycin 
and ceftriaxone was 60% and 48% respectively, 
which was also considered as moderate resistance.
DISCUSSION
 Gonorrhea is a sexually transmitted infection af-
fecting comparatively younger age group and 15-24 
years age group constituted the highest number in 
both gender in the present investigation. Further, 
people from low income group were more vulner-
able to contract gonorrhea. These sociodemographic 
factors contributing to higher prevalence rate of gon-
orrhea were similar as documented in different re-
ports.12,13 The reasons of common sociodemographic 
factors worldwide may be well correlated with the 
facts that people of this age and social class groups 
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Table-II: Antimicrobial susceptibility testing 
of N. gonorrhoeae isolates (n =25).
Antimicrobials Sensitive No. (%)
Resistant 
No. (%)
Penicillin (10 µg) 03(12) 22(88)
Tetracycline (30 µg) 05(20) 20(80)
Cotrimoxazole (25 µg) 05(20) 20(80)
Erythromycin (15 µg) 07(28) 18(72)
Ciprofloxacin (05 µg) 08(32) 17(68)
Cefixime (05 µg) 10(40) 15(60)
Azithromycin (15 µg) 10(40) 15(60)
Ceftriaxone (30 µg) 13(52) 12(48)
Table-I: Laboratory findings and their correlation with 
sociodemographic profile of gonorrhea patients (n=25).
Parameters Number (%)
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are more sexually active, mostly unmarried and 
unemployed and also largely influenced by wide-
spread and easy availability of internet-accessible 
electronic gadgets. All these factors are strong at-
tributes for their unprotected and promiscuous 
sexual activities to contract gonococcal infection.
 Regarding antimicrobial susceptibility, we ob-
served moderate to high (60-88%) resistance to con-
ventional antimicrobials including ciprofloxacin and 
cefixime and similar trend of resistance has been re-
ported over the time by many investigators.14,15,16 N. 
gonorrhoeae is a well-adapted human pathogen and 
notorious for its ever changing antimicrobial sus-
ceptibility for decades. Penicillin, sulphonamides 
and tetracycline are of no use in the treatment of 
gonorrhea since long. In 1993, ciprofloxacin, a fluo-
roquinolone, and two cephalosporins (ceftriaxone 
and cefixime) were the recommended treatments 
for gonorrhea. However, in the late 1990s and ear-
ly 2000s, ciprofloxacin resistance was detected and 
within a few years it became widespread in different 
countries that warned US Centre for Disease Control 
(CDC)in 2007 to stop its recommendation as empiric 
treatment for gonorrhea.17 Again following contin-
ued declines in cefixime susceptibility, CDC up-
dated its recommendations in 2012 to recommend 
injectable ceftriaxone plus either azithromycin or 
doxycycline as the only first-line treatment.18In 2015, 
CDC’s STD treatment guidelines recommended 
only one regimen of dual therapy for the treatment 
of gonorrhea; the injectable cephalosporin, ceftri-
axone, plus oral azithromycin.7 Unfortunately, as it 
always goes with N. gonorrhoeae, this latest regimen 
also turns to be ineffective at least partially with 
the prevalence of N. gonorrhoeae found resistant to 
azithromycin (RTA) and decreased susceptibility to 
ceftriaxone (DSC) detected in China in a large scale 
retrospective study and also reported from a few 
countries in Europeand the Americas.9,12,19,20 Simi-
lar in the line, we also noted moderate resistance 
to azithromycin (60%) and ceftriaxone (48%), the 
current dual therapy for gonorrhea in our present 
investigation.Our results show much higher rate of 
resistance for these two drugs in comparing with 
contemporary research findings which is alarming 
though but not unusual for a pathogen like N. gonor-
rhoeae. It is unclear whether circulating gonococcal 
strains with altered susceptibility to the key antibi-
otics acquired mutations through domestic selective 
pressure in Bangladesh or whether the strains have 
been imported. Experience says that both are pos-
sible here because macrolides like azithromycin has 
been used very frequently for trivial causes and it 
is also the antibiotic of choice for a number of other 
common bacterial infections. Similarly, the ceftriax-
one is also being used as first line antibiotic for many 
bacterial and non-bacterial etiologies in both com-
munity and hospitals unfortunately. Moreover, all 
antibiotics including these two very potential drugs 
are always available as over the counter drugs in 
Bangladesh. As a result it is quite logical to consider 
the strong probability of antibiotic abuse leading to 
drug resistance acquired by N. gonorrhoeae through 
selective pressure. Another very alarming and un-
ethical practice of antibiotic abuse in Bangladesh 
is its unrestricted use in poultry and cattle farming 
which is thought to be an important attribute for de-
veloping increasing antibiotic resistance in human 
treatment. Besides, because of increasing globaliza-
tion and migration of people now-a-days, increased 
resistance to antibiotics due to imported drug-resist-
ant gonococcal strains can’t also be ruled out. 
 Increased resistance to most antibiotics has raised 
concerns about the eventual development of un-
treatable gonococcal infections with serious sexual 
and reproductive health consequences. To address 
the changing situation, gonococcal treatment guide-
lines need to be updated. It is strongly recommend-
ed that countries like Bangladesh should establish 
standard national treatment protocols based on the 
local epidemiological and antimicrobial susceptibil-
ity data. Further, immediate introduction of ban on 
selling antibiotics as over the counter drugs, prac-
tice of strict antibiotic policies, enhancing facilities 
for proper laboratory diagnosis with antimicrobial 
susceptibility could be additional measures to stop 
drug resistance in gonorrhea.
Limitations: There are some potential limitations 
of present investigation. First, this was a cross-sec-
tional survey taking very small number of patients 
attending at a tertiary care facility, so it doesn’t 
represent the actual situation of country-wide an-
timicrobial resistance to N. gonorrhoeae. Second, we 
couldn’t determine minimal inhibitory concentra-
tion (MIC) of antibiotics especially ceftriaxone, so 
it might have been an over estimation for resistance 
to ceftriaxone. Third, there was no scope to carry 
out molecular typing of N. gonorrhoeae isolates. Fu-
ture studies should include molecular and genomic 
analyses to investigate gonorrhea transmission and 
to track the spread of antimicrobial resistance.
CONCLUSIONS
 Current status of gonococcal antimicrobial 
susceptibility has revealed moderate resistance 
to azithromycin and ceftriaxone, dual therapy 
recommended by the WHO for the treatment of 
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genital gonorrhea in the present investigation which 
is quite alarming. Selection of gonorrhea treatment 
should ideally be guided by culture and sensitivity 
test and empirical therapy must be considered based 
on recent antibiogram of a particular geographical 
area. Reevaluation of present treatment guideline 
is urgent before gonorrhea becomes an untreatable 
condition especially in countries like Bangladesh.
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